| Estradot 25 micrograms/24 hours, transdermal patch PA23311/004/005 |
Estradiol |
Sandoz Pharmaceuticals d.d. |
Not marketed |
| Estradot 37.5 micrograms/24 hours, transdermal patch PA23311/004/001 |
Estradiol |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Estradot 50 micrograms/24 hours, transdermal patch PA23311/004/002 |
Estradiol |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Estradot 75 micrograms/24 hours, transdermal patch PA23311/004/003 |
Estradiol |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Etoposide 20 mg/ml concentrate for solution for infusion PA2059/036/001 |
Etoposide |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Eucardic 12.5 mg Tablets PA2239/001/002 |
Carvedilol |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| Eucardic 25 mg Tablets PA2239/001/003 |
Carvedilol |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| Eucardic 6.25 mg Tablets PA2239/001/001 |
Carvedilol |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| Eucreas EU/1/07/425/16-18 |
Vildagliptin, Metformin hci |
Novartis Europharm Limited |
— |
| Eucreas 50 mg/1000 mg film-coated tablets EU/1/07/425/7-12 |
Metformin hci, Vildagliptin |
Novartis Europharm Limited |
— |
| Eucreas 50 mg/850 mg film-coated tablets EU/1/07/425/13-15 |
Vildagliptin, Metformin hci |
Novartis Europharm Limited |
— |
| Eucreas 50 mg/850 mg film-coated tablets EU/1/07/425/1-6 |
Metformin hci, Vildagliptin |
Novartis Europharm Limited |
— |
| Eumovate Cream 0.05% w/w PA1077/006/001 |
CLOBETASONE BUTYRATE |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Euphrasia HOR1149/011/001 |
Euphrasia officinalis |
A. Nelson & Company Limited |
Not marketed |
| Eurartesim 160 mg/20 mg film-coated tablets EU/1/11/716/005 |
Dihydroartemisinin, Piperaquine phosphate |
Sigma-Tau Industrie Farmaceutiche Riunite SpA |
— |
| Eurartesim 320 mg/40 mg film-coated tablets EU/1/11/716/001-004 |
Piperaquine phosphate, Dihydroartemisinin |
Alfasigma S.p.A |
— |
| Eurax 10% w/w Cream PA0126/325/001 |
Crotamiton |
Clonmel Healthcare Ltd |
Marketed |
| EURneffy 1 mg nasal spray, solution in single-dose container EU/1/24/1846/003-004 |
Epinephrine |
ALK-Abello A/S |
— |
| EURneffy 2 mg Nasal spray solution EU/1/24/1846/001-002 |
Adrenaline |
ALK-Abello A/S |
— |
| EVENITY 105 mg solution for injection in pre-filled pen EU/1/19/1411/001-002 |
ROMOSOZUMAB |
UCB Pharma S.A. |
— |
| EVENITY 105 mg solution for injection in pre-filled syringe EU/1/19/1411/003-004 |
ROMOSOZUMAB |
UCB Pharma S.A. |
— |
| Evfraxy 60 mg solution for injection in pre-filled syringe EU/1/25/1946/001 |
Denosumab |
Biosimilar Collaborations Ireland Limited |
— |
| Eviplera 200 mg/25 mg/245 mg film-coated tablets EU/1/11/737/001-002 |
Rilpivirine hydrochloride, Tenofovir disoproxil fumarate (tdf), Emtricitabine |
Gilead Sciences Ireland UC |
— |
| Evista 60 mg film coated tablets EU/1/98/073/001 |
Raloxifene |
Substipharm |
— |
| Evista 60 mg film coated tablets EU/1/98/073/002 |
Raloxifene |
Substipharm |
— |
| Evista 60 mg film coated tablets EU/1/98/073/003 |
Raloxifene |
Substipharm |
— |
| Evista 60 mg film coated tablets EU/1/98/073/004 |
Raloxifene |
Substipharm |
— |
| Evkeeza 150 mg/ml concentrate for solution for infusion EU/1/21/1551/001-002 |
Evinacumab |
Ultragenyx Germany GmbH |
— |
| Evoltra 1 mg/ml concentrate for solution for infusion EU/1/06/334/01-05 |
Clofarabine |
Sanofi B.V. |
— |
| EVOTAZ 300 mg/150 mg film-coated tablets EU/1/15/1025/001-002 |
Atazanavir, Cobicistat |
Bristol-Myers Squibb Pharma EEIG |
— |
| Evra EU/1/02/223/002 |
Norelgestromin, Ethinylestradiol |
Gedeon Richter Plc |
— |
| Evra EU/1/02/223/003 |
Norelgestromin, Ethinylestradiol |
Gedeon Richter Plc |
— |
| Evra 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch EU/1/02/223/001 |
Norelgestromin, Ethinylestradiol |
Gedeon Richter Plc |
— |
| Evrenzo 100 mg Film-coated tablet EU/1/21/1574/004 |
Roxadustat |
Astellas Pharma Europe B.V. |
— |
| Evrenzo 150 mg Film-coated tablet EU/1/21/1574/005 |
Roxadustat |
Astellas Pharma Europe B.V. |
— |
| Evrenzo 20 mg Film-coated tablet EU/1/21/1574/001 |
Roxadustat |
Astellas Pharma Europe B.V. |
— |
| Evrenzo 50 mg Film-coated tablet EU/1/21/1574/002 |
Roxadustat |
Astellas Pharma Europe B.V. |
— |
| Evrenzo 70 mg Film-coated tablet EU/1/21/1574/003 |
Roxadustat |
Astellas Pharma Europe B.V. |
— |
| Evrysdi 0.75 mg/mL powder for oral solution EU/1/21/1531/001 |
Risdiplam |
Roche Registration GmbH |
— |
| Evrysdi 5 mg film-coated tablets EU/1/21/1531/002 |
Risdiplam |
Roche Registration GmbH |
— |
| EVUSHELD 150 mg + 150 mg solution for injection EU/1/22/1651/001 |
Tixagevimab, Cilgavimab |
AstraZeneca AB |
— |
| EXBLIFEP 2 g/0.5 g powder for concentrate for solution for infusion EU/1/24/1794/001 |
Cefepime dihydrochloride monohydrate, Enmetazobactam |
Advanz Pharma Limited |
— |
| Exelon 1.5 mg hard capsules EU/1/98/066/001-003 |
Rivastigmine hydrogen tartrate |
Novartis Europharm Limited |
— |
| Exelon 13.3 mg/24 h transdermal patch EU/1/98/066/027-030 |
Rivastigmine |
Novartis Europharm Limited |
— |
| Exelon 2 mg/ml oral solution EU/1/98/066/013 |
Rivastigmine hydrogen tartrate |
Novartis Europharm Limited |
— |
| Exelon 3.0 mg hard capsules EU/1/98/066/004-006 |
Rivastigmine hydrogen tartrate |
Novartis Europharm Limited |
— |
| Exelon 4.5 mg hard capsules EU/1/98/066/007-009 |
Rivastigmine hydrogen tartrate |
Novartis Europharm Limited |
— |
| Exelon 4.6 mg/24 h transdermal patch EU/1/98/066/19-22 |
Rivastigmine |
Novartis Europharm Limited |
— |
| Exelon 6.0 mg hard capsules EU/1/98/066/010-012 |
Rivastigmine hydrogen tartrate |
Novartis Europharm Limited |
— |
| Exelon 9.5 mg/24 h transdermal patch EU/1/98/066/23-26 |
Rivastigmine |
Novartis Europharm Limited |
— |